Pulmonary Hypertension Research Act of 2003

The Pulmonary Hypertension Research Act of 2003 (H.R. 1316) was designed to expand federal efforts to combat pulmonary hypertension, a serious condition involving high blood pressure in the arteries of the lungs. The bill would have required the National Heart, Lung, and Blood Institute to increase funding for research into the causes and treatments of the disease while establishing specialized centers for clinical study and professional training.

For citizens and patients, the bill aimed to improve health outcomes by creating a national data system to track patient populations and an information clearinghouse to provide the public with better access to medical knowledge. These measures were intended to accelerate the development of new therapies, improve early diagnosis, and ensure that both healthcare providers and families had the most up-to-date information on managing the condition. Although the bill was introduced and referred to a subcommittee, it did not advance further to become law.